<DOC>
	<DOCNO>NCT00000207</DOCNO>
	<brief_summary>The purpose study test efficacy safety buprenorphine .</brief_summary>
	<brief_title>Multicenter Clinical Trial Buprenorphine - 3</brief_title>
	<detailed_description>12 different site total 736 subject ( 60 Pizarro , 70 West LA Tx center , 15 1 year extension )</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F , age 2150. opiate dependence accord DSMIV criterion . Selfreported use within last 30 day . Agreeable condition study sign informed consent . Psychiatric disorder require medication therapy . History seizure . Pregnant and/or nursing woman . Dependence ETOH benzodiazepine sedativehynotics . Acute hepatitis . Other medical condition deem participation unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Buprenorphine</keyword>
	<keyword>Opioid</keyword>
</DOC>